Research chemical comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-09-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
| Property | Value | Notes |
|---|---|---|
| Molecular target | PPAR delta (NR1C2) | Ligand-activated nuclear receptor. |
| Primary tissues studied | Skeletal muscle, liver, adipose | Effects on fatty acid oxidation and energy use. |
| Typical detection matrix | Urine | Used in anti-doping analysis. |
| Common analytical method | LC-MS/MS | Detects parent compound and metabolites. |
| Sport regulatory class | Prohibited at all times | Listed as a metabolic modulator by WADA. |
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Contamination with various chemicals have been identified. Some products contained trace amounts of the drugs tadalafil and rimonabant. The amount of either of these substances that is able to transfer from liquid to vapor phase is low. The nicotine impurities in the e-liquid varies greatly across companies. The levels of toxic chemicals in e-cigarette vapor is in some cases similar to that of nicotine replacement products. Tobacco-specific nitrosamines (TSNAs) such as nicotine-derived nitrosamine ketone (NNK) and N-Nitrosonornicotine (NNN) and tobacco-specific impurities have been found in the e-cigarette vapor at very low levels, comparable to amounts found in nicotine replacement products. A 2014 study that tested 12 e-cigarette devices found that most of them contained tobacco-specific nitrosamines in the e-cigarette vapor. In contrast, the one nicotine inhaler tested did not contain tobacco-specific nitrosamines. N-Nitrosoanabasine and N'-Nitrosoanatabine have been found in the e-cigarette vapor at lower levels than cigarette smoke. Tobacco-specific nitrosamines (TSNAs), nicotine-derived nitrosamine ketone (NNK), N-Nitrosonornicotine (NNN), and N′-nitrosoanatabine have been found in the e-cigarette vapor at different levels between different devices. Since e-liquid production is not rigorously regulated, some e-liquids can have amounts of impurities higher compared to limits for pharmaceutical-grade nicotine products.
deoxyribonucleotide A nucleotide containing deoxyribose as its pentose sugar component, and the monomer or subunit used to build deoxyribonucleic acid (DNA) molecules. Deoxyribonucleotides canonically incorporate any of four nitrogenous bases: adenine (A), guanine (G), cytosine (C), and thymine (T). Compare ribonucleotide.
==== Experiment in bacteria ==== Lunzer et al. tested the outcome of swapping divergent amino acids between two orthologous proteins of isopropylmalate dehydrogenase (IMDH). They substituted 168 amino acids in Escherichia coli IMDH that are wild type residues in IMDH Pseudomonas aeruginosa. They found that over one third of these substitutions compromised IMDH enzymatic activity in the Escherichia coli genetic background. This demonstrated that identical amino acid states can result in different phenotypic states depending on the genetic background. Corrigan et al. 2011 demonstrated how Staphylococcus aureus was able to grow normally without the presence of lipoteichoic acid due to compensatory mutations. Whole genome sequencing results revealed that when Cyclic-di-AMP phosphodiesterase (GdpP) was disrupted in this bacterium, it compensated for the disappearance of the cell wall polymer, resulting in normal cell growth. Research has shown that bacteria can gain drug resistance through compensatory mutations that do not impede or having little effect on fitness. Previous research from Gagneux et al. 2006 has found that laboratory grown Mycobacterium tuberculosis strains with rifampicin resistance have reduced fitness, however drug resistant clinical strains of this pathogenic bacteria do not have reduced fitness. Comas et al. 2012 used whole genome comparisons between clinical strains and lab derived mutants to determine the role and contribution of compensatory mutations in drug resistance to rifampicin.
==== Pit closures ==== Heseltine's responsibilities also included Energy, as the separate Energy ministry was abolished. Electricity companies now decided on their own contracts, rather than being obliged by the government to choose British coal. With plans being made for the privatisation of British Coal, on 13 October 1992 Heseltine and British Coal both separately announced that 31 of British Coal's 50 pits were to close, with the loss of 30,000 jobs. Most of the detailed work had been done by the minister of state Tim Eggar. Many of the mines in Nottinghamshire that had continued working during the 1984–1985 strike were to close. Although this policy was seen by the Nottinghamshire miners as a betrayal, there was hardly any organised resistance to the programme. The government stated that since the pits were losing money they could be sustained only through unjustifiable government subsidies. Mine supporters pointed to the mines' high productivity rates and to the fact that their monetary losses were due to the large subsidies that other European nations were giving to their coal industries. An early leak had seen little reaction but Heseltine was taken aback by the public anger. Over 100 pits had closed since the 1984–1985 strike. The closures were to be rushed because the Treasury, under pressure from Major, had agreed to make money for generous redundancy settlements available only in the 1992–1993 fiscal year.
Improving suppression of hemipteran vectors and bacterial pathogens of citrus and Solanaceous plants: Advances in Antisense Oligonucleotides (FANA). Front. Agron. 3:675247. doi:10.3389/fagro.2021.675247
Sources: en.wikipedia.org
Psilocybe cubensis grows naturally in tropical and subtropical conditions, often near cattle due to the ideal conditions they provide for the growth of the fungus. The cow usually consumes grains or grass covered with the spores of P. cubensis and the fungus will begin to germinate within the dung. Mushrooms such as Psilocybe cubensis are relatively easy to cultivate indoors. First, spores are inoculated within sterilized jars or bags, colloquially known as grainspawn, containing a form of carbohydrate nutrient such as rye or milo gains. After approximately one month, the spores fully colonize the grain spawn forming dense mycelium, which is then mixed within a bulk substrate such as a coconut husk fiber and vermiculite mixture. Given proper humidity, temperature, and fresh air exchange, the substrate will produce fruiting Psilocybe cubensis bodies within a month of planting. To preserve potency after harvesting, growers often dehydrate the fruit and store them in air-tight containers in cool environments. A study conducted in 2009 showed that mushrooms grown in the dark had higher levels of psilocybin and psilocin compared to the mushrooms grown in bright, indirect light, which had minimum levels. Studies were conducted where an environmentally controlled wind tunnel and a computer program were used to determine the influence of humidity on the individual basidiocarps of P. cubensis which aided in mapping their growth and development.
== Personal life == Wenger was married to former basketball player Annie Brosterhous, with whom he has one daughter, Léa (born 1997). In 2010, Wenger appealed for privacy after a British newspaper alleged he had an affair with a French singer. Wenger said in a statement that he wished to deal with the matter privately. Wenger and Brosterhous legally separated in 2015. As of 1999, Wenger spent his leisure time predominantly studying football matches; he once stated that he "watches games on most days", and holds an interest in politics. As of 2014, Wenger resided in Totteridge, London. Wenger acted as a football consultant for French television station TF1 from 2004 to 2014, and has worked for beIN Sports since 2016. Wenger was a world brand ambassador for FIFA World Cup sponsor Castrol. As part of the arrangement, he conducted several training camps for international youth teams worldwide to provide input to the Castrol Performance Index, FIFA's official ratings system. He has authored a book on football management exclusively for the Japanese market, Shōsha no Esupuri (勝者のエスプリ, lit. The Spirit of Conquest) in English, published by Japan Broadcast Publishing (a subsidiary of NHK) in August 1997. The book highlights his managerial philosophy, ideals, and values, as well as his thoughts on Japanese football and the game as a whole. Wenger is a Roman Catholic, and he attributes his outlook and values to his religious upbringing in Alsace.
== Hospitals == People's Hospital of Ningxia Hospital of Traditional Chinese Medicine of Ningxia Ningxia Medical College Affiliated Hospital Yinchuan Hospital of Traditional Chinese Medicine Yinchuan People's Hospital Yinchuan Stomatological Hospital Yinchuan Women and Children's Healthcare Center Women and Children's Healthcare Center of Ningixa Yinchuan No.1 People's Hospital Yinchuan No.2 People's Hospital Yinchuan No.3 People's Hospital Shizuishan No.2 People's Hospital Guyuan Hospital of Ningxia
Lactalbumin, also known as "whey protein", is the albumin contained in milk and obtained from whey. Lactalbumin is found in the milk of many mammals. There are alpha and beta lactalbumins; both are contained in milk. Targeted small scientific studies suggest that certain types of lactalbumin (whey protein) may improve immune responsiveness and increase levels of glutathione systemically in animals and which apparently possess antiviral (against viruses), anti-apoptotic (impede cell death) and anti-tumor (against cancers or tumors) activities in humans, but larger and better studies are needed to confirm these attributions.
Sources: en.wikipedia.org
According to generally accepted cosmology theory, only isotopes of hydrogen and helium, traces of some isotopes of lithium and beryllium, and perhaps some boron, were created at the Big Bang, while all other nuclides were synthesized later, in stars and supernovae, and in interactions between energetic particles such as cosmic rays, and previously produced nuclides. (See nucleosynthesis for details of the various processes thought responsible for isotope production.) The respective abundances of isotopes on Earth result from the quantities formed by these processes, their spread through the galaxy, and the rates of decay for isotopes that are unstable. After the initial coalescence of the Solar System, isotopes were redistributed according to mass, and the isotopic composition of elements varies slightly from planet to planet. This sometimes makes it possible to trace the origin of meteorites.
=== Chief executives === 1907–1962, James E. "Jim" Casey 1962–1972, George D. Smith 1972–1973, Paul Oberkotter 1973–1980, Harold Oberkotter 1980–1984, George Lamb 1984–1989, John W. Rogers 1989–1996, Kent C. "Oz" Nelson 1997–2001, James P. Kelly 2002–2007, Michael L. "Mike" Eskew 2008–2014, Scott Davis 2014–2020, David Abney 2020–current, Carol B. Tomé
The entry of U.S. troops into the war caused an intense increase in its industrial and agricultural production. However, the departure of U.S. soldiers left little labor for its economy; the remaining U.S. labor force was insufficient to meet the demands of the countryside and industry. Mexico and the United States signed an agreement in 1942 to regulate the flow of Mexican migrants (braceros) to the United States and compensate for the lack of U.S. workers. The agreement resulted in the Bracero Program. It established that braceros could not be employed in military service, could not suffer acts of discrimination, could not be used to displace U.S. workers, and that their basic needs had to be assured. The Bracero Program remained in effect until 1964 and benefited neighboring countries, securing needed labor for the United States and reducing unemployment in Mexico.
While many health insurance carriers in the United States do not reimburse for liposuction for lipedema, in 2020 several carriers regarded the procedure as reconstructive and medically necessary and did reimburse. Water Assisted Liposuction (WAL) is technically not considered to be tumescent but achieves the same goal as the anesthetic solution is injected as part of the procedure rather than before-hand. Developed by Doctor Ziah Taufig from Germany, it is usually performed under general anesthesia and is also considered to be lymph-sparing and protective of other tissues such as blood vessels.
=== Food fortification === Countries fortify foods with nutrients to address known deficiencies. As of 2020, 54 countries required food fortification of wheat flour with nicotinic acid or nicotinamide; 14 also mandate fortification of maize flour, and 6 mandate fortification of rice. From country to country, niacin fortification ranges from 1.3 to 6.0 mg/100 g.
Sources: en.wikipedia.org
It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.
Early-stage trials examined lipid and glucose markers, but the development program was discontinued. Published human results are limited and do not support approved use for any indication. Claims of performance or health benefits remain unproven.
Yes. Laboratories use LC-MS/MS to detect GW501516 and its metabolites in urine. Detection depends on timing and sensitivity, but the substance is banned at all times.
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.